NCT07117786 is a clinical trial of CT Contrast in Renal Cell Carcinoma (RCC), sponsored by First Affiliated Hospital of Fujian Medical University.

Who is sponsoring NCT07117786?

NCT07117786 is sponsored by First Affiliated Hospital of Fujian Medical University.

What drugs are being tested in NCT07117786?

Interventions in NCT07117786: CT Contrast, Computed Tomography.

What condition does NCT07117786 study?

NCT07117786 studies Renal Cell Carcinoma (RCC).

Is NCT07117786 still recruiting?

NCT07117786 is currently completed. Last updated 12 August 2025.

Last reviewed 2025-08-12 · How we verify

NCT07117786

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Computed Tomography Radiomics-Derived Nomogram for Predicting Early Renal Function Decline After Partial Nephrectomy in Renal Cell Carcinoma: A Multicenter Development/Validation Study

Completed Last updated 12 August 2025

What this trial tests

trial testing CT Contrast in Renal Cell Carcinoma (RCC) in 1,437 participants. Completed in 1 June 2023.

Timeline

1 January 2016

Primary endpoint
6 May 2023

1 June 2023

Quick facts

Lead sponsor	First Affiliated Hospital of Fujian Medical University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	1,437
Start date	1 January 2016
Primary completion	6 May 2023
Estimated completion	1 June 2023

Drugs / interventions tested

CT Contrast — full drug profile →
Computed Tomography

Conditions studied

Renal Cell Carcinoma (RCC) — all drugs for Renal Cell Carcinoma (RCC) →

Sponsor

First Affiliated Hospital of Fujian Medical University

Who can join

18 and older, any sex, with Renal Cell Carcinoma (RCC). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to explore the relationship between CT-based radiomics and postoperative renal function changes in patients with localized renal cell carcinoma (RCC) undergoing partial nephrectomy (PN). The main question it aims to answer is: Can a radiomics-clinical nomogram integrating CT-based radiomics features with preoperative and intraoperative clinical variables accurately predict early postoperative renal function decline in patients with localized RCC undergoing PN? Participants already undergoing renal CT examination and scheduled for postoperative renal function testing as part of the routine perioperative care will receive renal function assessment after completing surgical treatment for RCC.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Computed tomography radiomics-derived nomogram for prediciting early renal function decline after partial nephrectomy in renal cell carcinoma: a multicenter development/validation study.
Chen SH, Wu XH, Zeng CL, Zhao LN, et al · · 2026 · PMID 41586593 · DOI 10.1097/js9.0000000000004782

Verify or expand the search:

Other recruiting trials for Renal Cell Carcinoma (RCC)

Currently open trials in the same condition.

NCT07419841 — A Phase 1 Study of the Safety and Tolerability of CTX-10726 · Phase 1 · recruiting
NCT07402109 — CBCT Guided Markerless SBRT for Renal Cell Cancer · NA · recruiting
NCT07197580 — Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC · Phase 3 · recruiting
NCT07077161 — Cabozantinib Dose Skipping as an Alternative to Dose Reductions · Phase 2 · recruiting
NCT07181720 — CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors · Phase 1 · recruiting

Other First Affiliated Hospital of Fujian Medical University trials

Trials by the same sponsor.

NCT07513844 — Optimizing Parameters of Low-Intensity Focused Ultrasound for Pallidal Modulation in Huntington's Disease · NA · not yet recruiting
NCT07337772 — Comparing Different Doses of Corticosteroids in Local Infiltration Analgesia (LIA) for Total Knee Arthroplasty · NA · recruiting
NCT07369401 — Deep Brain Stimulation of the Nucleus Accumbens and Anterior Limb of the Internal Capsule in the Treatment of Refractory · NA · not yet recruiting
NCT07378358 — Evaluation of AI Large Models for Diagnosis and Treatment in Real-World Cases: Multicenter Retrospective Study · recruiting
NCT07363382 — The Value of GRPR PET Imaging for Diagnosis and Staging in Prostate Cancer · Phase 1, PHASE2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07117786 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by First Affiliated Hospital of Fujian Medical University
Last refreshed: 12 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07117786.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing